FATE THERAPEUTICS INC (FATE) Capital expenditures 2016–2025
FATE THERAPEUTICS INC (FATE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6.0MFY2025 · since FY2016: $457,000 → $6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.0M | +715.5% |
| FY2024 | $730,000 | -88.1% |
| FY2023 | $6.2M | -82.7% |
| FY2022 | $35.6M | -29.9% |
| FY2021 | $50.7M | +928.1% |
| FY2020 | $4.9M | -33.3% |
| FY2019 | $7.4M | +221.1% |
| FY2018 | $2.3M | +33.5% |
| FY2017 | $1.7M | +277.5% |
| FY2016 | $457,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice